Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Boehringer Ingelheim
Express Scripts
Harvard Business School
Covington

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 9,161,953

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,161,953
Title:GLP-1 receptor agonists for islet cell transplantation
Abstract: The disclosure provides methods for treating diabetes by promoting graft survival and improved graft function in a patient receiving an islet transplant by treating the patient with a GLP-1 receptor agonist compound prior to the islet transplant. The methods may also comprise treating the islets with a GLP-1 receptor agonist compound prior to transplanting them in a patient. The methods may eliminate the need for immunosuppressive therapy in islet transplants. Any GLP-1 receptor agonist compound know in the art can be used in the methods described herein.
Inventor(s): Osei; Kwame (San Diego, CA)
Assignee: Amylin Pharmaceuticals, LLC (Wilmington, DE) Eli Lilly And Company (Indianapolis, IN)
Application Number:13/996,093
Patent Claims:see list of patent claims

Details for Patent 9,161,953

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Glaxosmithkline Llc TANZEUM albiglutide INJECTABLE;INJECTION 125431 001 2014-04-15 ➤ Sign Up Amylin Pharmaceuticals, LLC (Wilmington, DE) Eli Lilly And Company (Indianapolis, IN) 2031-12-20 RX search
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 001 2015-03-09 ➤ Sign Up Amylin Pharmaceuticals, LLC (Wilmington, DE) Eli Lilly And Company (Indianapolis, IN) 2031-12-20 RX search
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 002 2015-03-09 ➤ Sign Up Amylin Pharmaceuticals, LLC (Wilmington, DE) Eli Lilly And Company (Indianapolis, IN) 2031-12-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Argus Health
Mallinckrodt
Baxter
Julphar
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.